Delivery Order SPE2DB20D7066-SPE2DB24FC1PR
Award Date 11/29/23
Potential Completion Date 11/30/23
Potential Value $47K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,625.87 for the supply of Emtricitabine-Tenofovir 200-300mg tablets. The contract has a firm fixed price and an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,267.59, is a Delivery Order for the procurement of Emtricitabine-Tenofovir 200-300 mg medication. It is a Firm Fixed Price contract with a completion date of March 7, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,187.91, is a delivery order for the supply of emtricitabine-tenofovir 200-300 mg tablets. The contract has an ultimate completion date of February 18, 2025 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,453.35, is for the delivery of emtricitabine-tenofovir 200-300 mg medications. The contract is a delivery order and has a firm fixed price pricing type, with a completion date of December 30, 2024. This award is not associated with a set-aside designation. AmerisourceBergen holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,878.79 firm fixed-price contract is to provide emtricitabine-tenofovir 200-300 mg tablets. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of emtricitabine-tenofovir 200-300 mg tablets. The $1,053.16 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that was awarded to the parent company, Cencora, Inc., doing business as Amerisourcebergen. This IDC serves as the primary vehicle for Amerisourcebergen to...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,949.47, is a delivery order for Emtricitabine-Tenofovir 200-300 mg medication in 30-count bottles. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of emtricitabine-tenofovir 200-300 milligram pharmaceuticals and is valued at $1,785.13. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a $5,490.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of emtricitabine-tenofovir 200-300mg tablets, a medication used to treat HIV. The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- The federal contract award is for the delivery of Emtricitabine-Tenofovir 200-300mg tablets, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,633.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 29, 2024, with a completion date of October 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...